Female gender, n (%) |
5 (56) |
5 (50) |
0.8087 |
BMI (kg/m2) |
24.2 ± 6.3 |
29.1 ± 4.9 |
0.0724 |
Dyspnea, n (%) |
6 (67) |
9 (90) |
0.2129 |
Cough, n (%) |
8 (89) |
6 (60) |
0.1533 |
Syncope, n (%) |
0 (0) |
2 (20) |
0.1561 |
Nausea, n (%) |
0 (0) |
1 (10) |
0.3297 |
Fatigue, n (%) |
5 (56) |
8 (80) |
0.2524 |
Fever, n (%) |
6 (67) |
7 (70) |
0.8759 |
COPD, n (%) |
0 (0) |
3 (30) |
0.0734 |
Previous pneumonia, n (%) |
1 (11) |
2 (20) |
0.5957 |
Smoking, n (%) |
2 (22) |
2 (20) |
0.9056 |
Arterial hypertension, n (%) |
4 (11) |
8 (80) |
0.1087 |
Previous stroke, n (%) |
0 (0) |
2 (20) |
0.1561 |
Diabetes mellitus, n (%) |
2 (22) |
3 (30) |
0.7007 |
Hyperlipidemia, n (%) |
2 (22) |
6 (60) |
0.0959 |
Coronary artery disease, n (%) |
0 (0) |
3 (30) |
0.0734 |
Previous myocardial infarction, n (%) |
0 (0) |
3 (30) |
0.0734 |
Heart valve disease, n (%) |
0 (0) |
1 (10) |
0.3297 |
Atrial fibrillation, n (%) |
1 (11) |
2 (20) |
0.5957 |
Previous cardiac surgery, n (%) |
0 (0) |
1 (10) |
0.3297 |
Chronic renal failure, n (%) |
1 (11) |
2 (20) |
0.5957 |
Liver disease, n (%) |
1 (11) |
0 (0) |
0.2788 |
Chronic venous disease, n (%) |
0 (0) |
1 (10) |
0.3297 |
Peripheral artery disease, n (%) |
1 (11) |
1 (10) |
0.9372 |
Hypothyroidism, n (%) |
3 (33) |
1 (20) |
0.2129 |
Leukocytes (G/l) |
5.82 ± 2.57 |
6.29 ± 2.30 |
0.8065 |
Neutrophils (%) |
71.4 ± 7.65 |
77.0 ± 10.6 |
0.3154 |
Lymphocytes (%) |
16.8 ± 6.62 |
14.5 ± 5.46 |
0.3675 |
Platelet count (cells) |
206.1 ± 100.1 |
173.6 ± 61.6 |
0.3072 |
INR |
1.10 ± 0.16 |
1.31 ± 0.84 |
0.8569 |
Quick |
84.4 ± 16.6 |
84.6 ± 25.7 |
0.7123 |
pTT |
27.8 ± 6.2 |
32.2 ± 9.4 |
0.2857 |
hs-TnT at admission (ng/l) |
8.12 ± 5.66 |
17.5 ± 10.5 |
0.0719 |
Left-ventricular ejection fraction at admission (%) |
73.1 ± 4.71 |
63.4 ± 7.61 |
0.0122 |
Correlation between EF and APACHE II at admission |
r: −0.5826 |
R2: 0.3394 |
0.02 |